{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:59:05Z","timestamp":1792688345102,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00467-018-4181-2","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T14:55:29Z","timestamp":1546440929000},"page":"581-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Pheochromocytoma and paraganglioma\u2014an update on diagnosis, evaluation, and management"],"prefix":"10.1007","volume":"35","author":[{"given":"Amrish","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Baracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"4181_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ncpendmet0396","volume":"3","author":"K Pacak","year":"2007","unstructured":"Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, AM MN, Tischler AS, International Symposium on Pheochromocytoma (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3:92\u2013102","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"4181_CR2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, Endocrine Society (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"key":"4181_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/his.13402","volume":"72","author":"J Turchini","year":"2018","unstructured":"Turchini J, Cheung VKY, Tischler AS, De Krijger RR, Gill AJ (2018) Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology 72:97\u2013105","journal-title":"Histopathology"},{"key":"4181_CR4","volume-title":"Hereditary paraganglioma-pheochromocytoma syndromes","author":"S Kirmani","year":"1993","unstructured":"Kirmani S, Young WF (1993) In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A (eds) Hereditary paraganglioma-pheochromocytoma syndromes. GeneReviews((R)), Seattle"},{"key":"4181_CR5","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3747\/co.21.1579","volume":"21","author":"M Lefebvre","year":"2014","unstructured":"Lefebvre M, Foulkes WD (2014) Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol 21:e8\u2013e17","journal-title":"Curr Oncol"},{"key":"4181_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1353.003","volume":"1073","author":"M Barontini","year":"2006","unstructured":"Barontini M, Levin G, Sanso G (2006) Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci 1073:30\u201337","journal-title":"Ann N Y Acad Sci"},{"key":"4181_CR7","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K (2011) Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29:4137\u20134142","journal-title":"J Clin Oncol"},{"key":"4181_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00467-008-0888-9","volume":"24","author":"B Havekes","year":"2009","unstructured":"Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K (2009) Update on pediatric pheochromocytoma. Pediatr Nephrol 24:943\u2013950","journal-title":"Pediatr Nephrol"},{"key":"4181_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.5858\/2008-132-1272-PAEPU","volume":"132","author":"AS Tischler","year":"2008","unstructured":"Tischler AS (2008) Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 132:1272\u20131284","journal-title":"Arch Pathol Lab Med"},{"key":"4181_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fped.2017.00155","volume":"5","author":"R Bholah","year":"2017","unstructured":"Bholah R, Bunchman TE (2017) Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr 5:155","journal-title":"Front Pediatr"},{"key":"4181_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","volume":"32","author":"JWM Lenders","year":"2017","unstructured":"Lenders JWM, Eisenhofer G (2017) Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab (Seoul) 32:152\u2013161","journal-title":"Endocrinol Metab (Seoul)"},{"key":"4181_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1634\/theoncologist.2008-0043","volume":"13","author":"JT Adler","year":"2008","unstructured":"Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, Sidhu SB (2008) Pheochromocytoma: current approaches and future directions. Oncologist 13:779\u2013793","journal-title":"Oncologist"},{"key":"4181_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14:108\u2013119","journal-title":"Nat Rev Cancer"},{"key":"4181_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1590\/2359-3997000000299","volume":"61","author":"PT Kavinga Gunawardane","year":"2017","unstructured":"Kavinga Gunawardane PT, Grossman A (2017) The clinical genetics of phaeochromocytoma and paraganglioma. Arch Endocrinol Metab 61:490\u2013500","journal-title":"Arch Endocrinol Metab"},{"key":"4181_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/jch.12084","volume":"15","author":"L Fishbein","year":"2013","unstructured":"Fishbein L, Orlowski R, Cohen D (2013) Pheochromocytoma\/paraganglioma: review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma. J Clin Hypertens (Greenwich) 15:428\u2013434","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4181_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2796.2009.02110.x","volume":"266","author":"CA Stratakis","year":"2009","unstructured":"Stratakis CA, Carney JA (2009) The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med 266:43\u201352","journal-title":"J Intern Med"},{"key":"4181_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ejhg.2015.142","volume":"24","author":"SA Boikos","year":"2016","unstructured":"Boikos SA, Xekouki P, Fumagalli E, Faucz FR, Raygada M, Szarek E, Ball E, Kim SY, Miettinen M, Helman LJ, Carney JA, Pacak K, Stratakis CA (2016) Carney triad can be (rarely) associated with germline succinate dehydrogenase defects. Eur J Hum Genet 24:569\u2013573","journal-title":"Eur J Hum Genet"},{"key":"4181_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/ijem.IJEM_558_16","volume":"21","author":"V Sarathi","year":"2017","unstructured":"Sarathi V (2017) Characteristics of pediatric Pheochromocytoma\/paraganglioma. Indian J Endocrinol Metab 21:470\u2013474","journal-title":"Indian J Endocrinol Metab"},{"key":"4181_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall'igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Racz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21:17\u201325","journal-title":"Endocr Relat Cancer"},{"key":"4181_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s13312-014-0397-9","volume":"51","author":"A Mishra","year":"2014","unstructured":"Mishra A, Mehrotra PK, Agarwal G, Agarwal A, Mishra SK (2014) Pediatric and adolescent pheochromocytoma: clinical presentation and outcome of surgery. Indian Pediatr 51:299\u2013302","journal-title":"Indian Pediatr"},{"key":"4181_CR21","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1210\/jc.2009-2830","volume":"95","author":"SG Waguespack","year":"2010","unstructured":"Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C (2010) A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95:2023\u20132037","journal-title":"J Clin Endocrinol Metab"},{"key":"4181_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366:665\u2013675","journal-title":"Lancet"},{"key":"4181_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1524-6175.2006.05712.x","volume":"8","author":"M Ceruti","year":"2006","unstructured":"Ceruti M, Petramala L, Cotesta D, Cerci S, Serra V, Caliumi C, Iorio M, De Toma G, Ciardi A, Vitolo D, Letizia C (2006) Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens (Greenwich) 8:642\u2013648","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4181_CR24","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"Welander J, Soderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253\u2013R276","journal-title":"Endocr Relat Cancer"},{"key":"4181_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41\u201351","journal-title":"Hum Mutat"},{"key":"4181_CR26","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1542\/peds.105.3.e34","volume":"105","author":"AD Torres","year":"2000","unstructured":"Torres AD, Rai AN, Hardiek ML (2000) Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics 105:E34","journal-title":"Pediatrics"},{"key":"4181_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ajcn\/75.3.561","volume":"75","author":"T Remer","year":"2002","unstructured":"Remer T, Neubert A, Maser-Gluth C (2002) Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75:561\u2013569","journal-title":"Am J Clin Nutr"},{"key":"4181_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-2265.2007.02805.x","volume":"66","author":"CG Perry","year":"2007","unstructured":"Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr (2007) The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol 66:703\u2013708","journal-title":"Clin Endocrinol"},{"key":"4181_CR29","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jcem.87.5.8446","volume":"87","author":"M Weise","year":"2002","unstructured":"Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G (2002) Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab 87:1955\u20131960","journal-title":"J Clin Endocrinol Metab"},{"key":"4181_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jso.23157","volume":"106","author":"PJ Mazzaglia","year":"2012","unstructured":"Mazzaglia PJ (2012) Hereditary pheochromocytoma and paraganglioma. J Surg Oncol 106:580\u2013585","journal-title":"J Surg Oncol"},{"key":"4181_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00441-018-2791-4","volume":"372","author":"D Taieb","year":"2018","unstructured":"Taieb D, Pacak K (2018) Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma. Cell Tissue Res 372:393\u2013401","journal-title":"Cell Tissue Res"},{"key":"4181_CR32","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc1101502","volume":"364","author":"NM Neary","year":"2011","unstructured":"Neary NM, King KS, Pacak K (2011) Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine. N Engl J Med 364:2268\u20132270","journal-title":"N Engl J Med"},{"key":"4181_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2017.5926","volume":"318","author":"F Hannah-Shmouni","year":"2017","unstructured":"Hannah-Shmouni F, Pacak K, Stratakis CA (2017) Metanephrines for evaluating palpitations and flushing. JAMA 318:385\u2013386","journal-title":"JAMA"},{"key":"4181_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.amjmed.2008.08.021","volume":"122","author":"R Yu","year":"2009","unstructured":"Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M (2009) Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med 122:85\u201395","journal-title":"Am J Med"},{"key":"4181_CR35","first-page":"679","volume":"39","author":"BL Shulkin","year":"1998","unstructured":"Shulkin BL, Shapiro B (1998) Current concepts on the diagnostic use of MIBG in children. J Nucl Med 39:679\u2013688","journal-title":"J Nucl Med"},{"key":"4181_CR36","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K (2012) Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 104:700\u2013708","journal-title":"J Natl Cancer Inst"},{"key":"4181_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4274\/Mirt.68552","volume":"22","author":"E Kocyigit Deveci","year":"2013","unstructured":"Kocyigit Deveci E, Ocak M, Bozkurt MF, Turker S, Kabasakal L, Ugur O (2013) The diagnostic efficiency of 99mTc-EDDA\/HYNIC-Octreotate SPECT-CT in comparison with 111In-pentetrotide in the detection of neuroendocrine tumours. Mol Imaging Radionucl Ther 22:76\u201384","journal-title":"Mol Imaging Radionucl Ther"},{"key":"4181_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cen.13163","volume":"86","author":"LM Gruber","year":"2017","unstructured":"Gruber LM, Erickson D, Babovic-Vuksanovic D, Thompson GB, Young WF Jr, Bancos I (2017) Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol 86:141\u2013149","journal-title":"Clin Endocrinol"},{"key":"4181_CR39","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1210\/js.2017-00230","volume":"1","author":"N Tufton","year":"2017","unstructured":"Tufton N, Sahdev A, Akker SA (2017) Radiological surveillance screening in asymptomatic succinate dehydrogenase mutation carriers. J Endocr Soc 1:897\u2013907","journal-title":"J Endocr Soc"},{"key":"4181_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-2007-996507","volume":"30","author":"J Schuttler","year":"1995","unstructured":"Schuttler J, Westhofen P, Kania U, Ihmsen H, Kammerecker S, Hirner A (1995) Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery. Anasthesiol Intensivmed Notfallmed Schmerzther 30:341\u2013349","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"4181_CR41","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/archsurg.1951.01250030644004","volume":"62","author":"V Apgar","year":"1951","unstructured":"Apgar V, Papper EM (1951) Pheochromocytoma. Anesthetic management during surgical treatment. AMA Arch Surg 62:634\u2013648","journal-title":"AMA Arch Surg"},{"key":"4181_CR42","first-page":"1480","volume":"86","author":"PF Plouin","year":"2001","unstructured":"Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G (2001) Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 86:1480\u20131486","journal-title":"J Clin Endocrinol Metab"},{"key":"4181_CR43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00268-004-7134-9","volume":"28","author":"DG Beltsevich","year":"2004","unstructured":"Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA (2004) Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg 28:592\u2013596","journal-title":"World J Surg"},{"key":"4181_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s00268-013-2325-x","volume":"38","author":"R Agrawal","year":"2014","unstructured":"Agrawal R, Mishra SK, Bhatia E, Mishra A, Chand G, Agarwal G, Agarwal A, Verma AK (2014) Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg 38:716\u2013723","journal-title":"World J Surg"},{"issue":"508","key":"4181_CR45","first-page":"e506","volume":"76","author":"TN Weingarten","year":"2010","unstructured":"Weingarten TN, Cata JP, O'Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E, Sprung J (2010) Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76(508):e506\u2013e511","journal-title":"Urology"},{"key":"4181_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","volume":"26","author":"C Prys-Roberts","year":"2002","unstructured":"Prys-Roberts C, Farndon JR (2002) Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 26:1037\u20131042","journal-title":"World J Surg"},{"key":"4181_CR47","first-page":"191","volume":"87","author":"S Kocak","year":"2002","unstructured":"Kocak S, Aydintug S, Canakci N (2002) Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg 87:191\u2013194","journal-title":"Int Surg"},{"key":"4181_CR48","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bja\/58.12.1453","volume":"58","author":"CJ Hull","year":"1986","unstructured":"Hull CJ (1986) Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth 58:1453\u20131468","journal-title":"Br J Anaesth"},{"key":"4181_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2265.2006.02571.x","volume":"65","author":"L Sibal","year":"2006","unstructured":"Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, Bliss R, Batchelor A, Perros P (2006) Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol 65:186\u2013190","journal-title":"Clin Endocrinol"},{"key":"4181_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2002.tb04408.x","volume":"970","author":"EL Bravo","year":"2002","unstructured":"Bravo EL (2002) Pheochromocytoma: an approach to antihypertensive management. Ann N Y Acad Sci 970:1\u201310","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"4181_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2165\/00003495-198400282-00004","volume":"28","author":"P Lund-Johansen","year":"1984","unstructured":"Lund-Johansen P (1984) Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. Drugs 28(Suppl 2):35\u201350","journal-title":"Drugs"},{"key":"4181_CR52","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(78)90772-9","volume":"1","author":"RS Briggs","year":"1978","unstructured":"Briggs RS, Birtwell AJ, Pohl JE (1978) Hypertensive response to labetalol in phaeochromocytoma. Lancet 1:1045\u20131046","journal-title":"Lancet"},{"key":"4181_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12020-013-0007-y","volume":"45","author":"A Mazza","year":"2014","unstructured":"Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G, Zuin M, Chondrogiannis S, Ravenni R, Opocher G, Colletti PM, Rubello D (2014) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45:469\u2013478","journal-title":"Endocrine"},{"key":"4181_CR54","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jch.12571","volume":"17","author":"M Romero","year":"2015","unstructured":"Romero M, Kapur G, Baracco R, Valentini RP, Mattoo TK, Jain A (2015) Treatment of hypertension in children with catecholamine-secreting tumors: a systematic approach. J Clin Hypertens (Greenwich) 17:720\u2013725","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4181_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","volume":"60","author":"G Lebuffe","year":"2005","unstructured":"Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, Vallet B, Proye CA (2005) The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 60:439\u2013444","journal-title":"Anaesthesia"},{"key":"4181_CR56","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.amjsurg.2007.08.028","volume":"194","author":"AD Ludwig","year":"2007","unstructured":"Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL (2007) Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg 194:792\u2013796 discussion 796-797","journal-title":"Am J Surg"},{"key":"4181_CR57","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","volume":"157","author":"J Steinsapir","year":"1997","unstructured":"Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr (1997) Metyrosine and pheochromocytoma. Arch Intern Med 157:901\u2013906","journal-title":"Arch Intern Med"},{"key":"4181_CR58","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1210\/jc.2012-3625","volume":"98","author":"O Petrak","year":"2013","unstructured":"Petrak O, Haluzikova D, Kavalkova P, Strauch B, Rosa J, Holaj R, Brabcova Vrankova A, Michalsky D, Haluzik M, Zelinka T, Widimsky J Jr (2013) Changes in energy metabolism in pheochromocytoma. J Clin Endocrinol Metab 98:1651\u20131658","journal-title":"J Clin Endocrinol Metab"},{"key":"4181_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1460-9592.2000.00504.x","volume":"10","author":"HA Hack","year":"2000","unstructured":"Hack HA (2000) The perioperative management of children with phaeochromocytoma. Paediatr Anaesth 10:463\u2013476","journal-title":"Paediatr Anaesth"},{"key":"4181_CR60","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00246-012-0564-5","volume":"34","author":"Y Kalra","year":"2013","unstructured":"Kalra Y, Agarwal HS, Smith AH (2013) Perioperative management of pheochromocytoma and catecholamine-induced dilated cardiomyopathy in a pediatric patient. Pediatr Cardiol 34:2013\u20132016","journal-title":"Pediatr Cardiol"},{"key":"4181_CR61","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinane.2009.01.017","volume":"22","author":"R Bryskin","year":"2010","unstructured":"Bryskin R, Weldon BC (2010) Dexmedetomidine and magnesium sulfate in the perioperative management of a child undergoing laparoscopic resection of bilateral pheochromocytomas. J Clin Anesth 22:126\u2013129","journal-title":"J Clin Anesth"},{"key":"4181_CR62","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/00000539-200211000-00024","volume":"95","author":"T Minami","year":"2002","unstructured":"Minami T, Adachi T, Fukuda K (2002) An effective use of magnesium sulfate for intraoperative management of laparoscopic adrenalectomy for pheochromocytoma in a pediatric patient. Anesth Analg 95:1243\u20131244","journal-title":"Anesth Analg"},{"key":"4181_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0022-5347(05)64896-3","volume":"168","author":"LN Castilho","year":"2002","unstructured":"Castilho LN, Castillo OA, Denes FT, Mitre AI, Arap S (2002) Laparoscopic adrenal surgery in children. J Urol 168:221\u2013224","journal-title":"J Urol"},{"key":"4181_CR64","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","volume":"198","author":"L Yip","year":"2004","unstructured":"Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB (2004) Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198:525\u2013534 discussion 534-525","journal-title":"J Am Coll Surg"},{"key":"4181_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1196\/annals.1353.044","volume":"1073","author":"M Mannelli","year":"2006","unstructured":"Mannelli M (2006) Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci 1073:405\u2013416","journal-title":"Ann N Y Acad Sci"},{"key":"4181_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/cen.12341","volume":"80","author":"LT van Hulsteijn","year":"2014","unstructured":"van Hulsteijn LT, Niemeijer ND, Dekkers OM, Corssmit EP (2014) (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol 80:487\u2013501","journal-title":"Clin Endocrinol"},{"key":"4181_CR67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12672-017-0284-7","volume":"8","author":"S Asai","year":"2017","unstructured":"Asai S, Katabami T, Tsuiki M, Tanaka Y, Naruse M (2017) Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas\/paragangliomas. Horm Cancer 8:108\u2013118","journal-title":"Horm Cancer"},{"key":"4181_CR68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fonc.2014.00166","volume":"4","author":"J Vogel","year":"2014","unstructured":"Vogel J, Atanacio AS, Prodanov T, Turkbey BI, Adams K, Martucci V, Camphausen K, Fojo AT, Pacak K, Kaushal A (2014) External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma. Front Oncol 4:166","journal-title":"Front Oncol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-018-4181-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4181-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4181-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T13:15:42Z","timestamp":1650114942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-018-4181-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4181"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4181-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"5 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors certify that they have no affiliation with organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}